DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on August 25, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Nonopioid Alternatives Pamphlet
July 2, 2019

Click here to access the pamphlet for “Information on Nonopioid Alternatives for the Treatment of Pain” Continue reading


Telehealth
July 1, 2019

Click here for information on the new law that sets standards of practice and authorizes out-of-state health care practitioners to perform telehealth services for patients in Florida. Continue reading